Arq, Inc. (ARQ) Q3 2025 10-Q Quarterly Report

Filed: Nov 5, 2025Period ending Sep 30, 2025
Health Care
Miscellaneous Chemical ProductsSEC EDGAR

Arq, Inc. (ARQ) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 5, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

Arq, Inc. Q3 2025 10-Q Analysis

Risk Factors

  • No new or changed risk factors disclosed compared to most recent 10-K
  • Continued forward-looking statement risks related to changing intentions without notice
+3 more insights

Arq, Inc. Q3 2025 Quarterly Financials
XBRL

Revenue

$35M

+0.9% YoY +22.7% QoQ

Net Income

-$653,000

-140.4% YoY +69.4% QoQ

Operating Margin

-2.4%

-822bp YoY +305bp QoQ

Net Margin

-1.9%

-651bp YoY +560bp QoQ

ROE

-0.3%

Total Assets

$278M

EPS (Diluted)

$-0.01

-120.0% YoY +80.0% QoQ

Operating Cash Flow

$5M

-31.0% YoY +906.5% QoQ

Source: XBRL data from Arq, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on Arq, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.